Acadia Healthcare (ACHC) reported Q4 adjusted diluted earnings Thursday of $0.64, down from $0.85 a year earlier.
Analysts polled by FactSet expected $0.71.
Revenue for the quarter ended Dec. 31 was $774.2 million, up from $742.8 million.
Analysts surveyed by FactSet expected $779 million.
The company said it expects Q1 revenue of $765 million to $775 million.
Analysts polled by FactSet expect $820.6 million.
For the full year 2025, the company expects adjusted EPS of $2.50 to $2.80 on $3.3 billion to $3.4 billion in revenue.
Analysts surveyed by FactSet expect $3.35 on revenue of $3.43 billion.
Additionally, Acadia said its board authorized a share repurchase program of up to $300 million for the company's outstanding common stock.
Shares of Acadia Healthcare were down over 14% in after-hours trading.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。